Trump Tariffs Threaten NHS Drug Price Crisis
Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.
Category : Search result: COVID19 medicines
NHS deploys 3 new COVID drugs for vulnerable
The NHS is rolling out three groundbreaking COVID-19 treatments to protect the most vulnerable, including molnupiravir and ritonavir, offering new hope for high-risk patients across the UK.
Six-month HIV prevention jab for 120 countries by 2027
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
NHS Drug Pricing: The Art of the Deal Saving Millions
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
NHS Must Reverse Medicines Investment Decline - Minister
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
WHO Adds Weight-Loss Jabs to Essential Medicines List
The World Health Organisation makes a landmark decision, adding weight-loss injections like Wegovy to its Essential Medicines List, signalling a new front in the global fight against obesity.
Trump’s Plan to Slash Drug Prices Sparks Big Pharma Backlash
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
EMA approves groundbreaking HIV prevention drug
The European Medicines Agency has approved a groundbreaking HIV prevention drug, marking a significant step forward in public health. Learn more about this medical milestone.
Page 1 of 1